<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Jim Cramer Recommends Eli Lilly Over Viking Therapeutics — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Jim Cramer Recommends Eli Lilly Over Viking Therapeutics</h2>
    <div class="badge">2025-09-08T15:58:59+00:00</div>
    <ul>
      <li>(NASDAQ:VKTX) stock has declined by nearly 23%.</li>
<li>The stock dropped over 40% between August 18 and 19 after the trial data of its oral anti-obesity drug showed that 20% of the patients dropped out due to negative effects.</li>
<li>READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.</li>
<li>Disclosure: None.</li>
<li>We have Eli Lilly.</li>
<li>Viking Therapeutics, Inc.</li>
<li>Why do we have to settle?</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Jim Cramer Recommends Eli Lilly Over Viking Therapeutics\n• (NASDAQ:VKTX) stock has declined by nearly 23%.\n• The stock dropped over 40% between August 18 and 19 after the trial data of its oral anti-obesity drug showed that 20% of the patients dropped out due to negative effects.\n• READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.\n• Disclosure: None.\n• We have Eli Lilly.\n• Viking Therapeutics, Inc.\n• Why do we have to settle?" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/jim-cramer-recommends-eli-lilly-155859708.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>